Dataset: Serum Follistatin-Like Protein 1 Is a Biomarker for Macrophage Activation Syndrome and May Predict Disease Course in Systemic Juvenile Idiopathic Arthritis
Objective. Follistatin-like protein 1 (FSTL-1) is a secreted glycoprotein that is over-expressed in certain inflammatory diseases. Our...
Objective. Follistatin-like protein 1 (FSTL-1) is a secreted glycoprotein that is over-expressed in certain inflammatory diseases. Our objective in this study was to correlate FSTL-1 levels with measures of clinical disease activity in systemic juvenile idiopathic arthritis (sJIA), including macrophage activation syndrome (MAS). Methods. FSTL-1 serum levels were measured by ELISA in 28 patients with sJIA, including 7 patients who developed MAS, as well as in 30 normal controls. Levels were correlated with erythrocyte sedimentation rate (ESR), ferritin and sIL-2Rα expression. Differential gene expression based on FSTL-1 levels was analyzed in peripheral blood mononuclear cells (PBMCs). Results. FSTL-1 serum levels were elevated at time of presentation (pre-treatment) of sJIA (mean 200.7 ng/ml) and decreased to normal (mean 133.7 ng/ml) over 24 months (p<0.01). FSTL-1 levels were markedly elevated during acute MAS (mean 279.8 ng/ml) and decreased to normal (mean 120.3 ng/ml) following treatment (p<0.001). FSTL-1 levels correlated with serum markers of inflammation, including sIL-2Rα and ferritin, in patients with MAS. PBMCs from patients with FSTL-1 levels >200 ng/ml showed an increase in expression of genes related to innate immunity and erythropoiesis, and decrease in NK cell function. Patients with the highest FSTL-1 levels at disease onset (>300 ng/ml) ultimately required cyclosporine treatment. Conclusion. In patients with sJIA, serum FSTL-1 is a biomarker for MAS and FSTL-1 levels at presentation may predict subsequent disease course. Patients with FSTL-1 levels >200 ng/ml had altered gene expression patterns suggestive of subclinical MAS and may represent a subgroup of sJIA with more severe disease. FSTL-1 serum levels were measured by ELISA in 28 patients with sJIA, including 7 patients who developed MAS, as well as in 30 normal controls. Levels were correlated with erythrocyte sedimentation rate (ESR), ferritin and sIL-2Rα expression. Differential gene expression based on FSTL-1 levels was analyzed in peripheral blood mononuclear cells (PBMCs). Only 11 patients were run on microarray.
- Species:
- human
- Samples:
- 11
- Source:
- E-GEOD-38849
- Updated:
- Dec.12, 2014
- Registered:
- Jul.11, 2014
| Sample | FSTL-1 NG/ML | TTF | RACE | AGE_AT_ONSET | SEX |
|---|---|---|---|---|---|
| GSM340378 | 242 | 65min | White | LT6 | male |
| GSM340376 | 248 | 70min | White | GTE6 | male |
| GSM340375 | 218 | 120min | White | LT6 | female |
| GSM340372 | 311 | 140min | White | GTE6 | female |
| GSM34037 | 176 | 70min | White | LT6 | female |
| GSM340370 | 222 | 110min | Black/African American | LT6 | male |
| GSM340363 | 118 | 100min | White | GTE6 | male |
| GSM340362 | 159 | 120min | White | LT6 | male |
| GSM34036 | 176 | 135min | Black/African American | GTE6 | male |
| GSM340360 | 187 | 80min | White | LT6 | female |
| GSM340358 | 94 | 125min | White | GTE6 | female |